GFAP and COVID-19: One study found that the brain injury markers NfL and GFAP, and inflammatory cytokines were elevated in COVID-19 and scaled with severity21–25; another study showed that baseline CSF NfL levels correlated with neurological outcomes at follow-up26 but overall, the relationships between these immune mediators and markers of brain injury and neuropathology remains to be fully explored.